| Date Filed | Type | Description |
| 05/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/04/2023 |
4
| SOUTHWELL DAVID P (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 2,571 shares
@ $50.0476, valued at
$128.7k
Exercised 2,571 options to buy
@ $18.01, valued at
$46.3k
|
|
| 03/31/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/27/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 02/06/2023 |
4
| SOUTHWELL DAVID P (CEO) has filed a Form 4 on TScan Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $1.81, valued at
$181k
|
|
| 01/09/2023 |
4
| SOUTHWELL DAVID P (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Granted 4,000 shares
@ $0
Granted 10,000 options to buy
@ $39.42, valued at
$394.2k
|
|
| 07/27/2022 |
4
| SOUTHWELL DAVID P (CEO) has filed a Form 4 on TScan Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $3.27, valued at
$327k
|
|
| 06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2022 |
4
| SOUTHWELL DAVID P (CEO) has filed a Form 4 on TScan Therapeutics, Inc.|
Txns:
| Bought 15,000 shares
@ $3.6226, valued at
$54.3k
Bought 10,000 shares
@ $3.5482, valued at
$35.5k
|
|
| 01/20/2022 |
4
| SOUTHWELL DAVID P (CEO) has filed a Form 4 on TScan Therapeutics, Inc.|
Txns:
| Granted 275,000 options to buy
@ $4.85, valued at
$1.3M
|
|
| 01/11/2022 |
4
| SOUTHWELL DAVID P (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Granted 3,200 shares
@ $0
Granted 12,000 options to buy
@ $38.1, valued at
$457.2k
|
|
| 12/27/2021 |
4
| SOUTHWELL DAVID P (CEO) has filed a Form 4 on TScan Therapeutics, Inc.|
Txns:
| Exercised 48,670 options to buy
@ $1.97, valued at
$95.9k
|
|
| 09/09/2021 |
4
| SOUTHWELL DAVID P (CEO) has filed a Form 4 on TScan Therapeutics, Inc.|
Txns:
| Bought 11,000 shares
@ $8.7333, valued at
$96.1k
|
|
| 07/15/2021 |
3
| SOUTHWELL DAVID P (CEO) has filed a Form 3 on TScan Therapeutics, Inc. |
| 06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/08/2021 |
4
| SOUTHWELL DAVID P (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Granted 1,650 shares
@ $0
Granted 10,000 options to buy
@ $66.49, valued at
$664.9k
|
|
| 10/20/2020 |
4
| SOUTHWELL DAVID P (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 14,300 shares
@ $51.503, valued at
$736.5k
Sold 700 shares
@ $52.183, valued at
$36.5k
Sold 11,500 shares
@ $51.516, valued at
$592.4k
Sold 500 shares
@ $52.178, valued at
$26.1k
Exercised 15,000 options to buy
@ $10.85, valued at
$162.8k
Exercised 12,000 options to buy
@ $11.23, valued at
$134.8k
|
|
| 06/18/2020 |
4
| SOUTHWELL DAVID P (Director) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.|
Txns:
| Granted 20,000 options to buy
@ $19.9, valued at
$398k
|
|
| 01/31/2020 |
4
| SOUTHWELL DAVID P (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Granted 1,650 shares
@ $0
Granted 10,000 options to buy
@ $51.16, valued at
$511.6k
|
|
| 01/30/2019 |
4
| SOUTHWELL DAVID P (Director) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.|
Txns:
| Granted 30,000 options to buy
@ $14.56, valued at
$436.8k
|
|
| 01/24/2019 |
4
| SOUTHWELL DAVID P (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Granted 14,000 options to buy
@ $33.02, valued at
$462.3k
|
|
| 12/14/2018 |
4
| SOUTHWELL DAVID P (Director) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.|
Txns:
| Sold 38,768 shares
@ $15.19, valued at
$588.9k
|
|
| 12/10/2018 |
4
| SOUTHWELL DAVID P (Director) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.|
Txns:
| Sold 52,809 shares
@ $15.15, valued at
$800.1k
Sold 4,923 shares
@ $14.91, valued at
$73.4k
Exercised 65,625 restricted stock units
@ $0 |
|
| 06/06/2018 |
4
| SOUTHWELL DAVID P (Director) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Granted 6,073 options to buy
@ $11.54, valued at
$70.1k
|
|
| 04/02/2018 |
4
| SOUTHWELL DAVID P (Director) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.|
Txns:
| Granted 40,000 options to buy
@ $18.75, valued at
$750k
Exercised 21,875 restricted stock units
@ $0 |
|
| 03/30/2018 |
4
| SOUTHWELL DAVID P (Director) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Granted 12,146 options to buy
@ $14.25, valued at
$173.1k
|
|
| 02/06/2018 |
3
| SOUTHWELL DAVID P (Director) has filed a Form 3 on Spero Therapeutics, Inc. |
| 01/05/2018 |
4
| SOUTHWELL DAVID P (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Granted 14,000 options to buy
@ $18.01, valued at
$252.1k
|
|
| 01/24/2017 |
4
| SOUTHWELL DAVID P (President and CEO) has filed a Form 4 on INOTEK PHARMACEUTICALS CORP |
| 01/09/2017 |
4
| SOUTHWELL DAVID P (President and CEO) has filed a Form 4 on INOTEK PHARMACEUTICALS CORP |
| 01/09/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|